No. 20-1110

Sandoz Inc., et al. v. Immunex Corporation, et al.

Lower Court: Federal Circuit
Docketed: 2021-02-12
Status: Denied
Type: Paid
Amici (1) Experienced Counsel
Tags: biosimilar-product double-patenting exclusivity federal-circuit invention obviousness obviousness-type-double-patenting patent patent-exclusivity patent-ownership substantial-rights
Key Terms:
Antitrust Patent
Latest Conference: 2021-05-13
Question Presented (from Petition)

Under federal patent law, a patent owner may receive only one period of exclusivity for its invention and may not obtain a second patent on the same invention or a "colorable variation" thereof. McCreary v. Pa. Canal Co., 141 U.S. 459, 467 (1891). The question presented is:

May the patent owner avoid the rule against double patenting by buying all of the substantial rights to a second, later-expiring patent for essentially the same invention, so long as the seller retains nominal ownership and a theoretical secondary right to sue for infringement?

Question Presented (AI Summary)

May the patent owner avoid the rule against double patenting by buying all of the substantial rights to a second, later-expiring patent for essentially the same invention, so long as the seller retains nominal ownership and a theoretical secondary right to sue for infringement?

Docket Entries

2021-05-17
Petition DENIED.
2021-04-27
DISTRIBUTED for Conference of 5/13/2021.
2021-04-26
Reply of petitioners Sandoz Inc., Sandoz International GmbH, Sandoz GmbH filed. (Distributed)
2021-04-12
Brief of respondents Immunex Corp., et al. in opposition filed.
2021-03-15
Brief amici curiae of Association for Accessible Medicines and America's Health Insurance Plans, Inc. filed.
2021-02-25
Motion to extend the time to file a response is granted and the time is extended to and including April 14, 2021.
2021-02-24
Motion to extend the time to file a response from March 15, 2021 to April 14, 2021, submitted to The Clerk.
2021-01-29
Petition for a writ of certiorari filed. (Response due March 15, 2021)

Attorneys

Association for Accessible Medicines and America's Health Insurance Plans, Inc.
Matthew S. HellmanJenner & Block LLP, Amicus
Immunex Corp., et al.
Constantine L. Trela Jr.Sidley Austin LLP, Respondent
Sandoz Inc., Sandoz International GmbH, Sandoz GmbH
William McGinley JayGoodwin Procter, LLP, Petitioner